
1. malar res treat. 2015;2015:279028. doi: 10.1155/2015/279028. epub 2015 jan 5.

occurrence pfatpase6 single nucleotide polymorphisms associated with
artemisinin resistance among field isolates plasmodium falciparum in
north-eastern tanzania.

chilongola j(1), ndaro a(1), tarimo h(1), shedrack t(1), barthazary s(2), kaaya
r(1), masokoto a(1), kajeguka d(1), kavishe ra(1), lusingu j(3).

author information: 
(1)kilimanjaro christian medical university college kilimanjaro clinical
research institute, moshi, tanzania.
(2)sokoine university agriculture, morogoro, tanzania.
(3)national institute medical research, tanga, tanzania.

we aimed determine current prevalence four p. falciparum candidate
artemisinin resistance biomarkers l263e, e431k, a623e, s769n pfatpase6
gene high transmission area tanzania retrospective cross sectional
study using 154 archived samples collected three previous malaria studies in
2010, 2011 2013. mutations pfatpase6 gene detected parasite dna
isolated dried blood spots using pcr-rflp. observed overall allelic
frequencies l263e, e431k, a623e, s769n 5.8% (9/154), 16.2%
(25/154), 0.0% (0/154), 3.9% (6/154). l263e mutation detected 
2010 occurred 3.9% 2.6% 2011 2013 respectively. l263e
mutation showed significant change frequency 2010 2011, 
between 2011 2013 (p < 0.05). frequency e431k highest without
any clear trend whereas s769n increased 2.2% 2010 3.6% 2011 and
5.1% 2013. a623e mutation detected. worrisome detection the
increase frequency s769n mutations calls urgent
assessment temporal changes known artemisinin biomarkers association
with vivo act efficacy.

doi: 10.1155/2015/279028 
pmcid: pmc4313681
pmid: 25685593 

